UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fibronectin type III domain‐containing 5 improves aging‐related cardiac dysfunction in mice

Aging cell, 2022-03, Vol.21 (3), p.e13556-n/a

2022

Volltextzugriff (PDF)

Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway

Redox biology, 2020-10, Vol.37, p.101747, Article 101747

2020

Volltextzugriff (PDF)

CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1

Journal of molecular and cellular cardiology, 2018-01, Vol.114, p.38-47

2018

Volltextzugriff (PDF)

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism

Cell biology and toxicology, 2021-12, Vol.37 (6), p.873-890

2021

Volltextzugriff (PDF)

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats

Diabetologia, 2017-06, Vol.60 (6), p.1126-1137

2017

Volltextzugriff (PDF)

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity

International journal of biological sciences, 2019, Vol.15 (3), p.556-567

2019

Volltextzugriff (PDF)

Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in mice

Molecular and cellular endocrinology, 2018-11, Vol.476, p.27-36

2018

Volltextzugriff (PDF)

T-bet deficiency attenuates cardiac remodelling in rats

Basic research in cardiology, 2018-05, Vol.113 (3), p.19-12, Article 19

2018

Volltextzugriff (PDF)

Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways

EBioMedicine, 2017-04, Vol.18 (C), p.179-187

2017

Volltextzugriff (PDF)

S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice

Journal of the American Heart Association, 2024-05, Vol.13 (10), p.e028006

2024

Volltextzugriff (PDF)

Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury

Cell reports (Cambridge), 2022-06, Vol.39 (11), p.110955-110955, Article 110955

2022

Volltextzugriff (PDF)

Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways

Journal of pharmacological sciences, 2017-11, Vol.135 (3), p.97-104

2017

Volltextzugriff (PDF)

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice

PPAR research, 2019, Vol.2019 (2019), p.1-11

2019

Volltextzugriff (PDF)

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways

PPAR Research, 2016-01, Vol.2016 (2016), p.1-11

2016

Volltextzugriff (PDF)

Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis

Frontiers in cardiovascular medicine, 2022-07, Vol.9, p.955237-955237

2022

Volltextzugriff (PDF)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

PPAR Research, 2017-01, Vol.2017 (2017), p.1-12

2017

Volltextzugriff (PDF)

Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury

International journal of biological sciences, 2022-01, Vol.18 (7), p.2703-2713

2022

Volltextzugriff (PDF)

C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice

Cardiovascular research, 2019-05, Vol.115 (6), p.1067-1077

2019

Volltextzugriff (PDF)

PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy

Cytokine (Philadelphia, Pa.), 2022-09, Vol.157, p.155932-155932, Article 155932

2022

Volltextzugriff (PDF)

USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart

Circulation (New York, N.Y.), 2024-02, Vol.149 (9), p.684-706

2024

Volltextzugriff (PDF)

Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway

International journal of biological sciences, 2016-05, Vol.12 (7), p.861-871

2016

Volltextzugriff (PDF)

ATF3: A potential target for cardiac maladaptive remodeling

International journal of cardiology, 2016-01, Vol.202, p.50-51

2016

Volltextzugriff (PDF)

Pioglitazone protected against cardiac hypertrophy via inhibiting AKT/GSK3[beta][beta] and MAPK signaling pathways

PPAR research, 2016-01, Vol.2016

2016

Volltextzugriff (PDF)

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats

Diabetologia, 2017-06, Vol.60 (6), p.1126-1137

2017

Volltextzugriff (PDF)

GW27-e0407 Bezafibrate protected against cardiac hypertrophy via inhibiting AKT/GSK-3β and MAPK signaling pathways

Journal of the American College of Cardiology, 2016-10, Vol.68 (16), p.C17-C17

2016

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

KollektionNature_系列刊

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fibronectin type III domain‐containing 5 improves aging‐related cardiac dysfunction in mice

Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway

CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity

Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in mice

T-bet deficiency attenuates cardiac remodelling in rats

Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways

S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice

Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury

Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways

Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury

C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice

PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy

USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart

Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway

ATF3: A potential target for cardiac maladaptive remodeling

Pioglitazone protected against cardiac hypertrophy via inhibiting AKT/GSK3[beta][beta] and MAPK signaling pathways

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats

GW27-e0407 Bezafibrate protected against cardiac hypertrophy via inhibiting AKT/GSK-3β and MAPK signaling pathways

Aktive Filter

Suchergebnisse filtern